Lantus, the new long-acting "peakless" insulin

You'll soon be able to prescribe Lantus, the new long-acting "peakless" insulin.

It was approved last year...but Aventis had to postpone the launch until they had an adequate supply.

Lantus is an insulin analog called insulin glargine. It differs from human insulin by 3 amino acids.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote